Literature DB >> 24216761

Identification of a novel protein interaction motif in the regulatory subunit of casein kinase 2.

Jennifer Yinuo Cao1, Kathy Shire, Cameron Landry, Gerald D Gish, Tony Pawson, Lori Frappier.   

Abstract

Casein kinase 2 (CK2) regulates multiple cellular processes and can promote oncogenesis. Interactions with the CK2β regulatory subunit of the enzyme target its catalytic subunit (CK2α or CK2α') to specific substrates; however, little is known about the mechanisms by which these interactions occur. We previously showed that by binding CK2β, the Epstein-Barr virus (EBV) EBNA1 protein recruits CK2 to promyelocytic leukemia (PML) nuclear bodies, where increased CK2-mediated phosphorylation of PML proteins triggers their degradation. Here we have identified a KSSR motif near the dimerization interface of CK2β as forming part of a protein interaction pocket that mediates interaction with EBNA1. We show that the EBNA1-CK2β interaction is primed by phosphorylation of EBNA1 on S393 (within a polyserine region). This phosphoserine is critical for EBNA1-induced PML degradation but does not affect EBNA1 functions in EBV replication or segregation. Using comparative proteomics of wild-type (WT) and KSSR mutant CK2β, we identified an uncharacterized cellular protein, C18orf25/ARKL1, that also binds CK2β through the KSSR motif and show that this involves a polyserine sequence resembling the CK2β binding sequence in EBNA1. Therefore, we have identified a new mechanism of CK2 interaction used by viral and cellular proteins.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24216761      PMCID: PMC3911286          DOI: 10.1128/MCB.00968-13

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  73 in total

1.  Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization.

Authors:  Vivian Saridakis; Yi Sheng; Feroz Sarkari; Melissa N Holowaty; Kathy Shire; Tin Nguyen; Rongguang G Zhang; Jack Liao; Weontae Lee; Aled M Edwards; Cheryl H Arrowsmith; Lori Frappier
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

2.  Specification of SUMO1- and SUMO2-interacting motifs.

Authors:  Christina-Maria Hecker; Matthias Rabiller; Kaisa Haglund; Peter Bayer; Ivan Dikic
Journal:  J Biol Chem       Date:  2006-03-08       Impact factor: 5.157

3.  Candidate psychiatric illness genes identified in patients with pericentric inversions of chromosome 18.

Authors:  Ben S Pickard; M Pat Malloy; Leanne Clark; Stéphanie Lehellard; Henrik L Ewald; Ole Mors; David J Porteous; Douglas H R Blackwood; Walter J Muir
Journal:  Psychiatr Genet       Date:  2005-03       Impact factor: 2.458

4.  Regulation of the EBNA1 Epstein-Barr virus protein by serine phosphorylation and arginine methylation.

Authors:  Kathy Shire; Priya Kapoor; Ke Jiang; Margaret Ng Thow Hing; Nirojini Sivachandran; Tin Nguyen; Lori Frappier
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells.

Authors:  Sean F Eddy; Shangqin Guo; Elizabeth G Demicco; Raphaëlle Romieu-Mourez; Esther Landesman-Bollag; David C Seldin; Gail E Sonenshein
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

6.  Analysis of the phosphorylation sites of herpes simplex virus type 1 regulatory protein ICP27.

Authors:  Y Zhi; R M Sandri-Goldin
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

7.  EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance.

Authors:  K Shire; D F Ceccarelli; T M Avolio-Hunter; L Frappier
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

8.  Hepatitis C virus NS2 protein is phosphorylated by the protein kinase CK2 and targeted for degradation to the proteasome.

Authors:  Nathalie Franck; Jacques Le Seyec; Christiane Guguen-Guillouzo; Lars Erdtmann
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

9.  Cooperative phosphorylation of the tumor suppressor phosphatase and tensin homologue (PTEN) by casein kinases and glycogen synthase kinase 3beta.

Authors:  Anna Maria Al-Khouri; Yuliang Ma; Summanuna H Togo; Scott Williams; Tomas Mustelin
Journal:  J Biol Chem       Date:  2005-08-17       Impact factor: 5.157

10.  Regulation of casein kinase 2 by direct interaction with cell surface receptor CD5.

Authors:  C Raman; A Kuo; J Deshane; D W Litchfield; R P Kimberly
Journal:  J Biol Chem       Date:  1998-07-24       Impact factor: 5.157

View more
  12 in total

1.  The Epstein-Barr Virus BMRF1 Protein Activates Transcription and Inhibits the DNA Damage Response by Binding NuRD.

Authors:  Samuel G Salamun; Justine Sitz; Carlos F De La Cruz-Herrera; Jaime Yockteng-Melgar; Edyta Marcon; Jack Greenblatt; Amelie Fradet-Turcotte; Lori Frappier
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

2.  Identification of ARKL1 as a Negative Regulator of Epstein-Barr Virus Reactivation.

Authors:  Umama Z Siddiqi; Anup S Vaidya; Xinliu Li; Edyta Marcon; Sai Wah Tsao; Jack Greenblatt; Lori Frappier
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

3.  Co-Localization of Insulin-Like Growth Factor Binding Protein-1, Casein Kinase-2β, and Mechanistic Target of Rapamycin in Human Hepatocellular Carcinoma Cells as Demonstrated by Dual Immunofluorescence and in Situ Proximity Ligation Assay.

Authors:  Sahil S Singal; Karen Nygard; Manthan R Dhruv; Kyle Biggar; Majida A Shehab; Shawn S-C Li; Thomas Jansson; Madhulika B Gupta
Journal:  Am J Pathol       Date:  2017-10-14       Impact factor: 4.307

Review 4.  The intrinsic disorder alphabet. III. Dual personality of serine.

Authors:  Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2015-03-17

5.  The intracellular domain of teneurin-1 induces the activity of microphthalmia-associated transcription factor (MITF) by binding to transcriptional repressor HINT1.

Authors:  Jonas Schöler; Jacqueline Ferralli; Stéphane Thiry; Ruth Chiquet-Ehrismann
Journal:  J Biol Chem       Date:  2015-02-03       Impact factor: 5.157

6.  A Screen for Epstein-Barr Virus Proteins That Inhibit the DNA Damage Response Reveals a Novel Histone Binding Protein.

Authors:  Ting-Hin Ho; Justine Sitz; Qingtang Shen; Ariane Leblanc-Lacroix; Eric I Campos; Ivan Borozan; Edyta Marcon; Jack Greenblatt; Amelie Fradet-Turcotte; Dong-Yan Jin; Lori Frappier
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

Review 7.  EBNA1-targeted inhibitors: Novel approaches for the treatment of Epstein-Barr virus-associated cancers.

Authors:  Lijun Jiang; Chen Xie; Hong Lok Lung; Kwok Wai Lo; Ga-Lai Law; Nai-Ki Mak; Ka-Leung Wong
Journal:  Theranostics       Date:  2018-10-22       Impact factor: 11.556

8.  Placental Mammals Acquired Functional Sequences in NRK for Regulating the CK2-PTEN-AKT Pathway and Placental Cell Proliferation.

Authors:  Beni Lestari; Satomi Naito; Akinori Endo; Hidenori Nishihara; Akira Kato; Erika Watanabe; Kimitoshi Denda; Masayuki Komada; Toshiaki Fukushima
Journal:  Mol Biol Evol       Date:  2022-02-03       Impact factor: 16.240

9.  Modular transcriptional repertoire and MicroRNA target analyses characterize genomic dysregulation in the thymus of Down syndrome infants.

Authors:  Carlos Alberto Moreira-Filho; Silvia Yumi Bando; Fernanda Bernardi Bertonha; Filipi Nascimento Silva; Luciano da Fontoura Costa; Leandro Rodrigues Ferreira; Glaucio Furlanetto; Paulo Chacur; Maria Claudia Nogueira Zerbini; Magda Carneiro-Sampaio
Journal:  Oncotarget       Date:  2016-02-16

10.  ERK2 phosphorylation of EBNA1 serine 383 residue is important for EBNA1-dependent transactivation.

Authors:  Ka-Won Noh; Jihyun Park; Eun Hye Joo; Eun Kyung Lee; Eun Young Choi; Myung-Soo Kang
Journal:  Oncotarget       Date:  2016-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.